Abstract
During the past 15 years the techniques available to detect ventricular arrhythmias in hospitalized and ambulatory patients have been developed to permit characterization and quantitation of the ventricular arrhythmias, 1 These advances have permitted the assessment of ventricular arrhythmia in many cardiac disorders and determination of their importance in the natural history of each syndrome. 2 Recently, a number of new antiarrhythmic drugs have been developed to provide the cardiologist a number of highly effective therapeutic agents for almost all ventricular arrhythmias. 3 However, each advance has raised new problems such as stratifying patients requiring treatment, documenting the effects of treatment and assessing the impact of treatment, on the natural history of the cardiac disorder. The report focuses on the latest available information about the detection and treatment of ventricular arrhythmias.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. C. Harrison, J. W. Fitzgerald, R. A. Winkle, Contribution of Ambulatory Electrocardiographic Monitoring to Antiarrhythmic Management, Am. J. Cardiol. 41: 996–1004 (1978).
D. C. Harrison, J. W. Fitzgerald, R. A. Winkle, Ambulatory Electrocardiography for Diagnosis and Treatment of Cardiac Arrhythmias, New Eng. J. Med. 294: 373–380 (1976).
D. L. D. Keefe, R. E . Kates, D. C. Harrison, New Antiarrhythmic Drugs: Their Place in Therapy, Drugs 22: 363–400 (1981).
D. C. Harrison, L. E. Berte, Should Prophylactic Antiarrhythmic Drug Therapy Be Used in Acute Myocardial Infarction, Clin. Cardiol. 247: 2019–2021 (1982).
H.S. Ribner, E. S. Isaacs, W. H. Frishman, Lidocaine Prophylaxis Against Ventricular Fibrillation in Acute Myocardial Infarction, Prog. Cardiovasc. Dis. 21: 287–313 (1979).
M. G. Wyman, L. Hammersmith, Comprehensive Treatment Plan for the Prevention of Primary Ventricular Fibrillation in Acute Myocardial Infarction, Am. J. Cardiol. 33: 661–667 (1974).
D. C. Harrison, P. J. Meffin, R. A. Winkle, Clinical Pharmacokinetics of Antiarrhythmic Drugs, Prog. Cardiovasc. Dis. 20: 217–242 (1977).
R. A. Winkle, Indications for Ambulatory ECG Monitoring, in: “Cardiology Update,” E. Rapaport, ed., (1981), Elsevier New York.
J. T. Bigger, C. A. Heller, T. L. Wenger, F. M. Weld, Risk Stratification After Acute Myocardial Infarction, Am. J. Cardiol. 42: 202–210 (1978).
W. Ruberman, E. Weinblatt, J. Goldberg, C. W. Frank, S. Shapiro, Ventricular Premature Beats and Mortality After Myocardial Infarction, New Eng. J. Med. 297: 750–757 (1977).
R. A. Winkle, Antiarrhythmic Drug Effect Mimicked by Spontaneous Variability of Ventricular Ectopy. Circulation 57: 1116–1121 (1978).
J. Morganroth, E. L. Michelson, L. N. Horowitz, M. E. Josephson, A. S. Pearlman, W. B.: Dunkman, Limitations of Routine Long-Term Electrocardiographic Monitoring to Assess Ventricular Ectopic Frequency, Circulation 58: 408–414 (1978).
M. Sami, H. Kraemer, D. C. Harrison, N. Houston, C. Shimaski, R. F. DeBusk, A New Method for Evaluating Antiarrhythmic Drug Efficacy, Circulation 62: 1172–1179 (1980).
Sudden Coronary Death, H. M. Greenberg and E. M. Dwyer, Jr., eds., Ann. New York Acad. Sci. 382: 1–483 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Harrison, D.C., Irwin, W.G. (1984). Detection and Treatment of Ventricular Arrhythmias. In: Chazov, E.I., Smirnov, V.N., Oganov, R.G. (eds) Cardiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1824-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1824-9_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1826-3
Online ISBN: 978-1-4757-1824-9
eBook Packages: Springer Book Archive